TABLE OF CONTENTS

Volume 41, Issue 8 (April (2) 2008)

Top

Review

Pulmonary veno-occlusive disease following hematopoietic stem cell transplantation: a rare model of endothelial dysfunction FREE

M C Bunte, M M Patnaik, M R Pritzker and L J Burns

Bone Marrow Transplant 41: 677-686; advance online publication, January 28, 2008; doi:10.1038/sj.bmt.1705990

Top

Special Report

The EBMT activity survey 2006 on hematopoietic stem cell transplantation: focus on the use of cord blood products FREE

A Gratwohl, H Baldomero, K Frauendorfer, V Rocha, J Apperley and D Niederwieser

Bone Marrow Transplant 41: 687-705; advance online publication, December 17, 2007; doi:10.1038/sj.bmt.1705956

Top

Commentary

Immune modulatory activity of ribavirin for serious human metapneumovirus disease: early i.v. therapy may improve outcomes in immunosuppressed SCT recipients FREE

A Safdar

Bone Marrow Transplant 41: 707-708; advance online publication, March 17, 2008; doi:10.1038/bmt.2008.80

Top

Original Articles

Allografting

Influence of killer immunoglobulin-like receptor/HLA ligand matching on achievement of T-cell complete donor chimerism in related donor nonmyeloablative allogeneic hematopoietic stem cell transplantation FREE

R M Sobecks, E J Ball, M Askar, K S Theil, L A Rybicki, D Thomas, S Brown, M Kalaycio, S Andresen, B Pohlman, R Dean, J Sweetenham, R Macklis, L Bernhard, K Cherni, E Copelan, J P Maciejewski and B J Bolwell

Bone Marrow Transplant 41: 709-714; advance online publication, January 14, 2008; doi:10.1038/sj.bmt.1705954

Autografting

Time of relapse after initial therapy significantly adds to the prognostic value of the IPI-R in patients with relapsed DLBCL undergoing autologous stem cell transplantation FREE

L J Costa, I N Micallef, D J Inwards, P B Johnston, L F Porrata and S M Ansell

Bone Marrow Transplant 41: 715-720; advance online publication, January 14, 2008; doi:10.1038/sj.bmt.1705967

Conditioning Regimens

High antileukemic efficacy of an intermediate intensity conditioning regimen for allogeneic stem cell transplantation in patients with high-risk acute myeloid leukemia in first complete remission FREE

C Schmid, M Schleuning, M Hentrich, G E Markl, A Gerbitz, J Tischer, G Ledderose, D Oruzio, W Hiddemann and H-J Kolb

Bone Marrow Transplant 41: 721-727; advance online publication, January 7, 2008; doi:10.1038/sj.bmt.1705965

Graft-Versus-Host Disease

Clinical characteristics of chronic graft-versus-host disease following umbilical cord blood transplantation for adults FREE

K Sugimoto, H Narimatsu, T Kawase, H Iida, M Watanabe, A Kohno, Y Kuwatsuka, T Uchida, M Hamaguchi, S Terakura, T Naoe, K Matsuo, M Murata, M Sawa, K Miyamura and Y Morishita

Bone Marrow Transplant 41: 729-736; advance online publication, January 7, 2008; doi:10.1038/sj.bmt.1705959

Post Transplant Events

BK-viruria and haemorrhagic cystitis are more frequent in allogeneic haematopoietic stem cell transplant patients receiving full conditioning and unrelated-HLA-mismatched grafts FREE

G Giraud, P Priftakis, G Bogdanovic, M Remberger, M Dubrulle, A Hau, R Gutmark, J Mattson, B-M Svahn, O Ringden, J Winiarski, P Ljungman and T Dalianis

Bone Marrow Transplant 41: 737-742; advance online publication, January 7, 2008; doi:10.1038/sj.bmt.1705962

Invasive pneumococcal disease in adult hematopoietic stem cell transplant recipients: a decade of prospective population-based surveillance FREE

D Kumar, A Humar, A Plevneshi, D Siegal, N Franke, K Green and A McGeer

Bone Marrow Transplant 41: 743-747; advance online publication, January 7, 2008; doi:10.1038/sj.bmt.1705964

Top

Letters to the Editor

Similar lymphocyte recovery and CMV reactivation profiles between reduced intensity conditioning with alemtuzumab and myeloablative allogeneic stem cell transplantation FREE

Q A Hill, A Hill, T A Collyns, R M Pearce and G Cook

Bone Marrow Transplant 41: 749-751; advance online publication, January 14, 2008; doi:10.1038/sj.bmt.1705974

High incidence of graft failure in unrelated cord blood transplantation using a reduced-intensity preparative regimen consisting of fludarabine and melphalan FREE

H Narimatsu, M Watanabe, A Kohno, K Sugimoto, Y Kuwatsuka, T Uchida, M Murata, K Miyamura and Y Morishita

Bone Marrow Transplant 41: 753-756; advance online publication, January 14, 2008; doi:10.1038/sj.bmt.1705978

Extra navigation

.

naturejobs

ADVERTISEMENT